1005787-84-7

Basic information

• Product Name: tert-butyl N-{6-iodoiMidazo[1,2-b]pyridazin-2- yl}carbaMate
• Synonyms: tert-butyl N-{6-iodoiMidazo[1,2-b]pyridazin-2- yl}carbaMate;tert-butyl (6-iodoimidazo[1,2-b]pyridazin-2-yl)carbamate
• CAS NO: 1005787-84-7
• Molecular Formula: C₁₁H₁₃IN₄O₂
• Molecular Weight: 360.15099
• Mol File: 1005787-84-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl N-{6-iodoiMidazo[1,2-b]pyridazin-2- yl}carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl N-{6-iodoiMidazo[1,2-b]pyridazin-2- yl}carbaMate(1005787-84-7)
• EPA Substance Registry System: tert-butyl N-{6-iodoiMidazo[1,2-b]pyridazin-2- yl}carbaMate(1005787-84-7)

Safety Data

• Hazardous Substances Data: 1005787-84-7(Hazardous Substances Data)

Upstream product

• 187973-60-0 6-iodopyridazine-3-amine 
• 120158-03-4 tert-butyl (2-chloroacetyl)carbamate 

Downstream Products

• 1005785-71-6 6-iodo-imidazo[1,2-b]pyridazin-2-ylamine 

Relevant articles and documents

IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF

The present disclosure provides compounds of Formula (I′) (e.g., compounds of Formula (I)), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, cocrystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof

FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF

The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.